Zachary Smith, DO

Publications

• Prolonged Gastrointestinal Manifestations After Recovery From COVID-19.

  (Elmunzer BJ, Palsson OS, Forbes N, Zakaria A, Davis C, Canakis A, Qayed E, Bick B, Pawa S, Tierney WM, McLeod CG, Taylor J, Patel H, Mendelsohn RB, Bala G, Sloan I, Merchant AA, Smith ZL, Sendzischew Shane MA, Aroniadis OC, Ordiah CO, Ruddy JM, Simren M, Tack J, Drossman D, Rome Foundation Research Institute and the North American Alliance for the Study of Digestive Manifestations of COVID-19.) Clin Gastroenterol Hepatol. 2024 May;22(5):1098-1107.e3 PMID: 37995983 11/24/2023

• Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial.

  (Elmunzer BJ, Foster LD, Serrano J, Coté GA, Edmundowicz SA, Wani S, Shah R, Bang JY, Varadarajulu S, Singh VK, Khashab M, Kwon RS, Scheiman JM, Willingham FF, Keilin SA, Papachristou GI, Chak A, Slivka A, Mullady D, Kushnir V, Buxbaum J, Keswani R, Gardner TB, Forbes N, Rastogi A, Ross A, Law J, Yachimski P, Chen YI, Barkun A, Smith ZL, Petersen B, Wang AY, Saltzman JR, Spitzer RL, Ordiah C, Spino C, Durkalski-Mauldin V, SVI Study Group.) Lancet. 2024 Feb 03;403(10425):450-458 PMID: 38219767 PMCID: PMC10872215 SCOPUS ID: 2-s2.0-85183679654 01/15/2024

• Incidence of Esophageal Adenocarcinoma, Mortality, and Esophagectomy in Barrett's Esophagus Patients Undergoing Endoscopic Eradication Therapy.

  (Smith ZL, Thorgerson AM, Dawson AZ, Wani S.) Dig Dis Sci. 2023 Dec;68(12):4439-4448 PMID: 37863992 SCOPUS ID: 2-s2.0-85174546982 10/21/2023

• Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic Cancer.

  (Thalji SZ, Fernando D, Dua KS, Madhavan S, Chisholm P, Smith ZL, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Evans DB, Tsai S.) Ann Surg. 2023 Dec 01;278(6):e1224-e1231 PMID: 37078282 SCOPUS ID: 2-s2.0-85176508848 04/20/2023

• ASO Visual Abstract: CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/ nab-Paclitaxel for Patients with Operable Pancreatic Cancer.

  (Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S.) Ann Surg Oncol. 2023 May;30(5):3022 PMID: 36877324 SCOPUS ID: 2-s2.0-85152164746 03/07/2023

• CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer.

  (Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S.) Ann Surg Oncol. 2023 May;30(5):3013-3021 PMID: 36788189 SCOPUS ID: 2-s2.0-85147934173 02/15/2023

• The incidence of new mental health disorders after acute pancreatitis: A large, propensity-matched, observational study.

  (Khoja K, Sadiq O, Chisholm PR, Dua KS, Madhavan S, Smith ZL.) Pancreatology. 2023 Mar;23(2):163-170 PMID: 36710225 SCOPUS ID: 2-s2.0-85148705757 01/30/2023

• Evidence-Based Cognitive Endoscopy Simulators: Do They Exist? A Systematic Search and Evaluation of Existing Platforms.

  (Shah R, Kurin M, Satyavada S, Ismail M, Smith Z, Davitkov P, Isenberg G, Gottumukkala R, Faulx A, Falck-Ytter Y, Chak A.) Dig Dis Sci. 2023 Mar;68(3):744-749 PMID: 35704254 PMCID: PMC9199333 SCOPUS ID: 2-s2.0-85132298848 06/16/2022

• ERCP-related adverse events: incidence, mechanisms, risk factors, prevention, and management.

  (Rivas A, Pherwani S, Mohamed R, Smith ZL, Elmunzer BJ, Forbes N.) Expert Rev Gastroenterol Hepatol. 2023;17(11):1101-1116 PMID: 37899490 SCOPUS ID: 2-s2.0-85175702275 10/30/2023

• Incidence of sedation-related adverse events during ERCP with anesthesia assistance: a multicenter observational study.

  (Cummings LC, Liang C, Mascha EJ, Saager L, Smith ZL, Bhavani S, Vargo JJ, Cummings KC 3rd.) Gastrointest Endosc. 2022 Aug;96(2):269-281.e1 PMID: 35381231 SCOPUS ID: 2-s2.0-85132875287 04/06/2022

• Consensus-based development of a causal attribution system for post-ERCP adverse events.

  (Forbes N, Elmunzer BJ, Keswani RN, Hilsden RJ, Hall M, Anderson JT, Arvanitakis M, Chen YI, Duloy A, Elta GH, Maranki JL, Mergener K, Petersen BT, Sethi A, Siersema PD, Smith ZL, Telford JJ, Tse F, Cotton PB, Wani S.) Gut. 2022 Jul 11 PMID: 35817552 SCOPUS ID: 2-s2.0-85138182417 07/12/2022

• Response to Giri and Darak.

  (Satyavada S, Smith ZL.) Am J Gastroenterol. 2022 May 01;117(5):811 PMID: 35315811 SCOPUS ID: 2-s2.0-85129996999 03/23/2022